RegeneRx Biopharmaceuticals, Inc. Stock Other OTC
Equities
RGRX
US75886X1081
Pharmaceuticals
Financials (USD)
Sales 2021 | 76.76K | Sales 2022 | 76.76K | Capitalization | 19.94M |
---|---|---|---|---|---|
Net income 2021 | -1M | Net income 2022 | -1M | EV / Sales 2021 | 298 x |
Net cash position 2021 | 66.69K | Net Debt 2022 | 1.16M | EV / Sales 2022 | 275 x |
P/E ratio 2021 |
-13.9
x | P/E ratio 2022 |
-11.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.86% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 86 | 82-05-12 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 83-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 83-12-31 |
Founder | 86 | 82-05-12 | |
Joe McNay
BRD | Director/Board Member | 90 | 01-12-31 |
1st Jan change | Capi. | |
---|---|---|
-3.70% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.44% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |